Trial Profile
Clinical and economic impact of transfer from efavirez/emtricitabine/tenofovir to rilpivirine/emtricitabine/tenofovir in a third level hospital.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 02 Dec 2015 New trial record